Format

Send to

Choose Destination
Haematologica. 2019 May 16. pii: haematol.2019.221333. doi: 10.3324/haematol.2019.221333. [Epub ahead of print]

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.

Author information

1
GIGA-I3 and CHU, University of Liege, Belgium; f.baron@ulg.ac.be.
2
Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.
3
Leiden University Medical Center, Leiden, Netherlands.
4
Radboud University Medical Center, Nijmegen, Netherlands, and King College Hospital, London, UK.
5
Hôtel-Dieu Hospital, Paris, France.
6
Department of Medicine and Experimental Oncology, University of Torino, Italy.
7
Gustave Roussy cancer campus Grand Paris, Villejuif, France.
8
Ospedali Riuniti.
9
University of Florence, Firenze, Italy.
10
Ospedale Civile, Pescara, Italy.
11
University of Bologna, Bologna, Italy.
12
Jules Bordet Institute, Brussels, Belgium.
13
Sapienza University of Rome, Rome, Italy.
14
Radboud University Medical Center, Nijmegen, Netherlands.
15
University Tor Vergata, Rome, Italy.
16
EORTC Headquarters, Brussels, Belgium.

KEYWORDS:

Acute Myeloid Leukemia; Stem Cell Transplantation; allo-BMT; auto-BMT

PMID:
31097634
DOI:
10.3324/haematol.2019.221333
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center